Serum caveolin-1 levels in patients with preeclampsia


Cift T., Begum A. M. , Cetin B. A. , Erenel H., Tuten A., Bulut B., ...More

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, vol.33, no.5, pp.712-717, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 5
  • Publication Date: 2020
  • Doi Number: 10.1080/14767058.2018.1500539
  • Title of Journal : JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
  • Page Numbers: pp.712-717

Abstract

Aim: The expressions of caveolin-1 have only been examined in the placental tissue of patients with preeclampsia and were reported to be low. Therefore, we decided to investigate the maternal serum levels of caveolin-1 in patients with preeclampsia. Material and methods: This cross-sectional study was conducted including 87 pregnant women; 32 with normal pregnancy and 55 with preeclampsia. Maternal serum levels of caveolin-1 were measured by using enzyme-linked immunosorbent assay kit (ELISA). Results: The mean serum caveolin-1 level was significantly lower in women with preeclampsia (PE) compared with the control group (11.48 +/- 0.92 versus 12.94 +/- 1.36 ng/ml) and being lowest in the early onset PE group (11.24 +/- 0.74 ng/ml). Serum caveolin-1 concentrations did not correlate with maternal age and BMI. However, caveolin-1 concentrations were negatively correlated with systolic blood pressure (r = -0.467, p = .001) and diastolic blood pressure (r = -0.441, p = .001) as well as with umbilical artery resistance index (r = -0.275, p = .01). Conclusion: Maternal serum caveolin-1 levels are significantly lower in patients with PE than controls. The serum caveolin-1 levels inversely correlate with blood pressure and umbilical artery Doppler parameters.